NEW
YORK
—
A
team
of
psychologists
in
Chicago
and
Toronto
have
released
a
report
that
indicates
that
many
self-proclaimed
bisexual
men
are
in
reality
gay
men
who
have
not
fully
accepted
their
sexual
orientation,
according
to
a
report
in
the
New
York
Times.
Researchers
measured
genital
arousal
patterns
in
men
as
they
were
shown
a
variety
of
sexual
imagery.
The
research
shows
that
men
who
claimed
to
be
bisexual
tended
to
be
aroused
only
by
one
gender,
usually
other
men.
“Research
on
sexual
orientation
has
been
based
almost
entirely
on
self-reports,
and
this
is
one
of
the
few
good
studies
using
physiological
measures,”
said
Dr.
Lisa
Diamond,
an
associate
professor
of
psychology
and
gender
identity
at
the
University
of
Utah,
who
was
not
involved
in
the
study.
The
study’s
senior
author,
Dr.
J.
Michael
Bailey
of
Northwestern
University,
faced
criticism
in
2003
from
transgender
activists
for
“The
Man
Who
Would
Be
Queen,”
a
controversial
book
about
gender
identity.
Other
researchers
said
Bailey’s
study
on
male
bisexuality
was
an
interesting
start,
but
needed
to
be
repeated
with
a
much
larger
survey
group,
the
Times
reported.
“The
last
thing
you
want,”
said
Dr.
Randall
Sell,
an
assistant
professor
of
clinical
socio-medical
sciences
at
Columbia
University,
“is
for
some
therapists
to
see
this
study
and
start
telling
bisexual
people
that
they’re
wrong,
that
they’re
really
on
their
way
to
homosexuality.”
WASHINGTON
(AP)
—
The
government’s
AIDS
research
agency
“is
a
troubled
organization”
and
its
managers
have
engaged
in
unnecessary
feuding,
sexually
explicit
language
and
other
inappropriate
conduct
that
hampers
its
global
fight
against
the
disease,
an
internal
review
found.
The
review
for
the
National
Institutes
of
Health
director’s
office,
obtained
by
the
Associated
Press,
substantiates
many
of
the
concerns
that
whistleblower
Dr.
Jonathan
Fishbein
raised
about
the
agency’s
AIDS
research
division
and
its
senior
managers.
The
division
suffers
from
“turf
battles
and
rivalries
between
physicians
and
Ph.D.
scientists”
and
the
situation
has
been
“rife
for
too
long,”
the
report
concluded.
Nonetheless,
the
NIH
formally
fired
Fishbein
last
week,
over
the
objections
of
several
members
of
Congress.
The
top
Republican
and
Democrat
on
the
Senate
Finance
Committee
are
protesting,
saying
the
firing
was
an
example
of
whistleblower
punishment.
NEW
YORK
(AP)
—
Pfizer
Inc.
said
last
week
that
it
is
abandoning
development
of
two
experimental
drugs
after
they
posted
poor
trial
results:
an
HIV
therapy
that
was
in
advanced
studies
and
a
treatment
for
a
smoking-related
lung
disease
that
the
company
was
developing
with
Germany’s
Altana
AG.
“These
are
clearly
important
drugs
in
their
own
right,
but
relative
to
Pfizer’s
overall
size
it
is
not
of
significant
consequence
to
their
long-term
earnings
potential,”
said
Robert
Hazlett,
an
analyst
at
Suntrust
Robinson
Humphrey.
Hazlett
said
he
expects
Pfizer’s
recent
agreement
to
buy
Vicuron
Pharmaceuticals,
Inc.,
to
largely
offset
any
investor
concerns
about
the
loss
of
the
two
potential
drugs.
Pfizer
said
it
dropped
the
capravirine
HIV
drug
because
two
studies
failed
to
show
that
it
significantly
helped
patients.
Specifically,
the
drug
did
not
boost
the
effectiveness
of
standard
triple-drug
HIV
therapies
in
patients
who
had
failed
to
respond
to
available
antiretroviral
therapies,
the
New
York-based
drug
maker
said.
JERUSALEM
—
A
new
study
finds
that
50
percent
of
dentists
in
Israel
will
not
treat
patients
with
HIV
or
AIDS,
the
Jerusalem
Post
reported.
Presented
at
the
Knesset
Labor,
Social
Affairs
and
Health
Committee
last
week,
the
research
was
conducted
by
six
dentists
as
part
of
their
work
to
achieve
a
master’s
degree
in
public
administration.
They
included
65
dentists
in
the
study,
and
half
said
they
would
not
treat
HIV/AIDS
patients,
the
Post
reported,
although
younger
dentists
were
more
willing
than
older
dentists
to
take
such
clients.
Dr.
Shlomo
Zusman,
Health
Ministry
dental
services
chief,
said
any
doctor
who
refuses
to
treat
a
patient
for
such
reasons
could
be
prosecuted
for
violating
law,
the
law.
Health
officials
acknowledged,
however,
that
few
if
any
complaints
from
HIV/AIDS
patients
against
dentists
who
would
not
treat
them
have
been
received,
likely
because
patients
want
to
keep
their
medical
conditions
private,
the
Post
reported.
